ReviewBurns & trauma2026
Microalgae: emerging forces and prospects in the field of wound healing.
Review in Burns & trauma, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Viable microalgal cells have recently emerged as promising photosynthetic components of advanced wound healing systems because they can combine light-regulated oxygen generation, bioactive metabolite production, intrinsic imaging potential, and engineering flexibility within a single platform. In wounds with impaired or threatened healing such as burn wounds, traumatic full-thickness wounds, infected wounds, and chronic diabetic wounds, hypoxia, excessive inflammation, microbial burden, and impaired angiogenesis collectively hinder tissue repair and limit the efficacy of the currently employed therapies. In this review, the mechanistic basis and translational potential of microalgae in wound care is examined, with a focus on photosynthesis-driven oxygenation, antimicrobial and anti-inflammatory activities, antioxidant effects, immunomodulation, and bioimaging capability. We further summarize how viable microalgal cells or cell-derived products have been incorporated into hydrogels, 3D-bioprinted scaffolds, microneedles, electrospun matrices, coatings, and other biohybrid systems to achieve localized oxygen delivery, therapeutic molecule release, and multifunctional wound intervention. Importantly, we discuss the wound type-specific suitability of different microalgae-based platforms and critically compare them with existing oxygenation and antimicrobial strategies. We also highlight key barriers to clinical translation, including immune-mediated clearance, uncertain long-term survival and photosynthetic persistence in hostile wound microenvironments, limited light penetration, biosafety concerns, and challenges in manufacturing and standardization. Overall, microalgae-based wound therapeutics represent a highly promising but still early-stage strategy, and future progress will depend on mechanism-driven design, rigorous
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.